BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 7184487)

  • 1. Lewis lung carcinoma in mice as an experimental therapy model. I. The growth kinetics and the effect of tumor on host.
    Budzyński W
    Arch Immunol Ther Exp (Warsz); 1982; 30(5-6):363-72. PubMed ID: 7184487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of interleukin 2 treatment combined with local hyperthermia in mice inoculated with Lewis lung carcinoma cells.
    Shen RN; Lu L; Wu B; Shidnia H; Hornback NB; Broxmeyer HE
    Cancer Res; 1990 Aug; 50(16):5027-30. PubMed ID: 2379168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Control of lung metastasis progression in mice: role of growth kinetics of 3LL Lewis lung carcinoma and host immune reactivity.
    Gorelik E; Segal S; Feldman M
    J Natl Cancer Inst; 1980 Dec; 65(6):1257-64. PubMed ID: 6933271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of surgery on the cell kinetics of residual tumor.
    Simpson-Herren L; Sanford AH? ; Holmquist JP
    Cancer Treat Rep; 1976 Dec; 60(12):1749-60. PubMed ID: 1026333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancement by cyclophosphamide of experimental pulmonary metastases formation of Lewis lung carcinoma. I. Dose-dependence and kinetics of cyclophosphamide effect.
    Strzadała L; Rak J; Kuśnierczyk H
    Arch Immunol Ther Exp (Warsz); 1985; 33(6):825-9. PubMed ID: 3833119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined therapy with a new bisphosphonate, minodronate (YM529), and chemotherapy for multiple organ metastases of small cell lung cancer cells in severe combined immunodeficient mice.
    Yano S; Zhang H; Hanibuchi M; Miki T; Goto H; Uehara H; Sone S
    Clin Cancer Res; 2003 Nov; 9(14):5380-5. PubMed ID: 14614023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between primary tumor volume and lung metastasis in Lewis lung carcinoma (1). Assay for time course of development of metastasis.
    Ohizumi Y; Maezawa H; Mori T
    Tokai J Exp Clin Med; 1987 Nov; 12(4):229-35. PubMed ID: 3503392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on antitumor effect of corynebacterium parvum and pustulan on Lewis lung carcinoma in mice.
    Budzyński W
    Arch Immunol Ther Exp (Warsz); 1982; 30(5-6):379-84. PubMed ID: 7184489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Control of progression of local tumor and pulmonary metastasis of the 3LL Lewis lung carcinoma by different histocompatibility requirements in mice.
    Isakov N; Feldman M; Segal S
    J Natl Cancer Inst; 1981 May; 66(5):919-26. PubMed ID: 6939934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitory effects of active substances isolated from Cassia garrettiana heartwood on tumor growth and lung metastasis in Lewis lung carcinoma-bearing mice (Part 1).
    Kimura Y; Baba K; Okuda H
    Anticancer Res; 2000; 20(5A):2899-906. PubMed ID: 11062699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancement by cyclophosphamide of experimental pulmonary metastases formation of Lewis lung carcinoma. II. Reduction of the cyclophosphamide effect by repopulation with cells from lymphoid organs.
    Strzadała L; Rak J; Kuśnierczyk H
    Arch Immunol Ther Exp (Warsz); 1985; 33(6):831-6. PubMed ID: 3914253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tyroservatide therapy for tumor growth, invasion and metastasis of Lewis lung carcinoma and human lung carcinoma A549.
    Zheng M; Lu R; Che X; Li J; Zhou C; Wang L; Xu Q; Cao H; Li Q; Yao Z
    Oncology; 2006; 70(6):418-26. PubMed ID: 17245103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of lung tumor growth and metastasis in mice by adeno-associated virus-mediated expression of vasostatin.
    Cai KX; Tse LY; Leung C; Tam PK; Xu R; Sham MH
    Clin Cancer Res; 2008 Feb; 14(3):939-49. PubMed ID: 18245558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemopoietic redistribution in tumor-bearing mice.
    Lala PK; Terrin M; Lind C; Kaizer L
    Exp Hematol; 1978 Mar; 6(3):283-98. PubMed ID: 648592
    [No Abstract]   [Full Text] [Related]  

  • 15. Observations on the antimetastatic action of lysozyme in mice bearing Lewis lung carcinoma.
    Sava G; Ceschia V; Pacor S; Zabucchi G
    Anticancer Res; 1991; 11(3):1109-13. PubMed ID: 1888145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of angiogenesis and metastases of the Lewis-lung cell carcinoma by the quinoline-3-carboxamide, Linomide.
    Borgström P; Torres Filho IP; Hartley-Asp B
    Anticancer Res; 1995; 15(3):719-28. PubMed ID: 7544090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased metastatic capacity of Lewis lung tumor cells by in vivo selection procedure.
    Pál K; Kopper L; Lapis K
    Invasion Metastasis; 1983; 3(3):174-82. PubMed ID: 6677625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of stem cell factor on the growth and radiation survival of tumor cells.
    Shui C; Khan WB; Leigh BR; Turner AM; Wilder RB; Knox SJ
    Cancer Res; 1995 Aug; 55(15):3431-7. PubMed ID: 7542170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FCE 27266, a sulfonic distamycin derivative, inhibits experimental and spontaneous lung and liver metastasis.
    Sola F; Farao M; Ciomei M; Pastori A; Mongelli N; Grandi M
    Invasion Metastasis; 1995; 15(5-6):222-31. PubMed ID: 8765197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The antitumor effect of postoperative treatment with genistein alone or combined with cyclophosphamide in mice bearing transplantable tumors.
    Wietrzyk J; Opolski A; Madej J; Radzikowski C
    Acta Pol Pharm; 2000 Nov; 57 Suppl():5-8. PubMed ID: 11293263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.